Home / CPN1 Knockout Cell Lines

CPN1 Knockout Cell Lines

Gene: CPN1

Official Full Name: carboxypeptidase N subunit 1provided by HGNC

Gene Summary: Carboxypeptidase N is a plasma metallo-protease that cleaves basic amino acids from the C terminal of peptides and proteins. The enzyme is important in the regulation of peptides like kinins and anaphylatoxins, and has also been known as kininase-1 and anaphylatoxin inactivator. This enzyme is a tetramer comprised of two identical regulatory subunits and two identical catalytic subunits; this gene encodes the catalytic subunit. Mutations in this gene can be associated with angioedema or chronic urticaria resulting from carboxypeptidase N deficiency. [provided by RefSeq, Jul 2008]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO38443 CPN1 Knockout cell line (A549) Human CPN1 1:3~1:4 Negative Online Inquiry

Background

CPN1 Gene Knockout Cell Lines are genetically modified cell lines designed to specifically disrupt the expression of the carboxypeptidase N (CPN1) gene, which encodes an enzyme involved in the regulation of bioactive peptides and play essential roles in various physiological processes. These cell lines are generated using advanced CRISPR/Cas9 technology, allowing for precise and efficient gene editing that results in complete knockout of CPN1 expression, facilitating the study of its biological functions and implications in disease pathways.

The primary function of CPN1 involves the hydrolytic cleavage of carboxy-terminal basic amino acids from peptide substrates, influencing numerous biological activities such as blood pressure regulation, immune response modulation, and inflammation. By utilizing CPN1 gene knockout cell lines, researchers can investigate the downstream effects of CPN1 loss on cellular metabolism, signaling pathways, and overall cell behavior. These insights are invaluable for understanding the roles of CPN1 in health and disease, including its potential influence in cancer progression, cardiovascular disorders, and inflammatory conditions.

The scientific importance of CPN1 knockout models extends to both basic and applied research fields, including pharmacology and toxicology, enabling researchers to assess drug impacts in a controlled setting. These cell lines provide a crucial tool for elucidating the molecular mechanisms underlying CPN1-related functions, paving the way for novel therapeutic interventions.

CPN1 Gene Knockout Cell Lines stand out in the market due to their high specificity, reproducibility, and ease of use compared to traditional gene silencing methods, such as siRNA or shRNA technologies. Moreover, they offer a longer-lasting genetic modification and a stable background devoid of CPN1 activity, enhancing experimental consistency and reliability.

For researchers and clinicians focused on gene function and the pathophysiology of diseases, these knockout cell lines represent an indispensable resource for advancing knowledge and driving discoveries. Our company prides itself on its state-of-the-art gene editing capabilities and commitment to providing high-quality biological products that empower scientific advancement. With extensive experience in cellular models and genetic engineering, we deliver innovative solutions that support research excellence and contribute to the development of cutting-edge therapies.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.